Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Fragasso

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
European Journal of Heart Failure|August 25, 2018
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitationCosmo Godino, Andrea Scotti, Andrea Munafò, et al.
Giornale Italiano Di Cardiologia (2006)|May 13, 2011
[Cardiac stem cell therapy for the treatment of chronic stable angina refractory to conventional therapy. State of the art and current clinical experience of the San Raffaele Hospital of Milan, Italy]Cosmo Godino, Carlo Briguori, Flavio Airoldi, et al.
Heart (British Cardiac Society)|February 23, 2019
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusionCosmo Godino, Alessia Giannattasio, Andrea Scotti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 29, 2022
Myocardial fibrosis in asymptomatic patients undergoing surgery for mitral and aortic valve regurgitationGabriele Fragasso, Francesca Sanvito, Giuseppe Monaca, et al.
Haematologica|March 20, 2025
Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19Gregorio Maria Bergonzi, Jacques-Emmanuel Galimard, Federico Mario Aletti, et al.
International Journal of Cardiology|June 23, 2018
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathyCosmo Godino, Andrea Scotti, Maurizio Taramasso, et al.
Echocardiography (Mount Kisco, N.Y.)|October 21, 2021
Subclinical myocardial dysfunction in patients recovered from COVID-19Leonardo Italia, Giacomo Ingallina, Antonio Napolano, et al.
European Journal of Heart Failure|June 16, 2025
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESCGabriele Fragasso, Davide Stolfo, Markus S Anker, et al.
European Journal of Heart Failure|October 17, 2020
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failurePetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
European Journal of Heart Failure|July 4, 2020
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
European Journal of Heart Failure|August 25, 2018
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitationCosmo Godino, Andrea Scotti, Andrea Munafò, et al.
Giornale Italiano Di Cardiologia (2006)|May 13, 2011
[Cardiac stem cell therapy for the treatment of chronic stable angina refractory to conventional therapy. State of the art and current clinical experience of the San Raffaele Hospital of Milan, Italy]Cosmo Godino, Carlo Briguori, Flavio Airoldi, et al.
Heart (British Cardiac Society)|February 23, 2019
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusionCosmo Godino, Alessia Giannattasio, Andrea Scotti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 29, 2022
Myocardial fibrosis in asymptomatic patients undergoing surgery for mitral and aortic valve regurgitationGabriele Fragasso, Francesca Sanvito, Giuseppe Monaca, et al.
Haematologica|March 20, 2025
Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19Gregorio Maria Bergonzi, Jacques-Emmanuel Galimard, Federico Mario Aletti, et al.
International Journal of Cardiology|June 23, 2018
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathyCosmo Godino, Andrea Scotti, Maurizio Taramasso, et al.
Echocardiography (Mount Kisco, N.Y.)|October 21, 2021
Subclinical myocardial dysfunction in patients recovered from COVID-19Leonardo Italia, Giacomo Ingallina, Antonio Napolano, et al.
European Journal of Heart Failure|June 16, 2025
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESCGabriele Fragasso, Davide Stolfo, Markus S Anker, et al.
European Journal of Heart Failure|October 17, 2020
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failurePetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
European Journal of Heart Failure|July 4, 2020
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
Pageof 12